Lonvi Biosciences, a Shenzhen-based startup, says its new grape seed–derived compound could destroy “zombie cells” and extend human life well beyond 100 years.
A Chinese biotechnology company, Lonvi Biosciences, has made bold claims that its newly developed anti-ageing pills could help humans live up to 150 years, marking what could be one of the most ambitious scientific pursuits in human longevity.
The Shenzhen-based startup says its experimental drug targets so-called “zombie cells”—aged cells that no longer divide but remain in the body, contributing to tissue damage and age-related diseases. By eliminating these cells, the company claims it can significantly slow the ageing process and extend lifespan.
“Living to 150 is definitely realistic,” said Lyu Qinghua, Lonvi’s Chief Technology Officer, in an interview with The New York Times. “In a few years, this will be the reality.”
The announcement follows recent remarks by Chinese President Xi Jinping and Russian President Vladimir Putin, who reportedly discussed longevity science and the possibility of living up to 150 years during a military parade in Beijing.
The Science Behind Lonvi’s Pill
Lonvi’s formula is built around a compound found in grape seed extract, known as Procyanidin C1 (PCC1). Research published in the journal Nature Metabolism previously demonstrated that PCC1 could extend the lifespan and health span of mice by targeting and destroying senescent cells—those that stop functioning properly but refuse to die.
According to Lonvi, their lab has found a way to isolate and reproduce high concentrations of this compound in capsule form, making it the foundation for what the company calls “the holy grail of anti-ageing.”
“This is not just another supplement. This is the holy grail,” said Yip Tszho, also known as Zico, Lonvi’s Chief Executive Officer. He added that, combined with a healthy lifestyle and proper medical care, the capsules could help people live well beyond 100 to 120 years.
Experts Urge Caution
While the company’s claims have drawn global attention, scientists have urged caution until large-scale clinical trials confirm the safety and efficacy of the treatment.
Dr. David Furman, Associate Professor at the Buck Institute for Research on Aging, told NYT that while the early findings “seem promising,” the science of human longevity remains complex and largely unproven.
“Senolytics—drugs that target senescent cells—are indeed a fascinating frontier,” Furman said. “But extending human life to 150 years is still a scientific stretch.”
Lonvi Biosciences maintains that it is preparing for human trials and remains confident that its discovery could revolutionize modern medicine and redefine what it means to grow old.
Disclaimer: This article is for informational purposes only. Always consult a qualified medical professional before starting any health, diet, or anti-ageing treatment.
Post a Comment